2022
DOI: 10.3390/molecules27123862
|View full text |Cite
|
Sign up to set email alerts
|

Analysis of Pros and Cons in Using [68Ga]Ga-PSMA-11 and [18F]PSMA-1007: Production, Costs, and PET/CT Applications in Patients with Prostate Cancer

Abstract: The aim of this work is to compare [68Ga]Ga-PSMA-11 and [18F]PSMA-1007 PET/CT as imaging agents in patients with prostate cancer (PCa). Comparisons were made by evaluating times and costs of the radiolabeling process, imaging features including pharmacokinetics, and impact on patient management. The analysis of advantages and drawbacks of both radioligands might help to make a better choice based on firm data. For [68Ga]Ga-PSMA-11, the radiochemical yield (RCY) using a low starting activity (L, average activit… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
6
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 13 publications
(10 citation statements)
references
References 21 publications
1
6
0
Order By: Relevance
“…This nding is consistent with that of previous studies investigating the diagnostic performance of [ 68 Ga]Ga-FAPI PET/CT in thyroid cancer [11,15]. In addition to an excellent rate of detection, other advantages of FAPI radioligands based on 18 F include long half-life, greater imaging quality, economic convenience, greater availability and consequent higher number of PET/CT examinations performed, which are promising alternatives and more practical to FAPI radioligands based on 68 Ga in clinical practice [21,22]. Furthermore, with the development of theranostics based on FAPI [13], [ 18 F]FAPI-42 PET/CT provides an opportunity for diagnostic imaging to evaluate the therapeutic feasibility and bene ts of FAPI-based targeted therapy.…”
Section: Discussionsupporting
confidence: 90%
“…This nding is consistent with that of previous studies investigating the diagnostic performance of [ 68 Ga]Ga-FAPI PET/CT in thyroid cancer [11,15]. In addition to an excellent rate of detection, other advantages of FAPI radioligands based on 18 F include long half-life, greater imaging quality, economic convenience, greater availability and consequent higher number of PET/CT examinations performed, which are promising alternatives and more practical to FAPI radioligands based on 68 Ga in clinical practice [21,22]. Furthermore, with the development of theranostics based on FAPI [13], [ 18 F]FAPI-42 PET/CT provides an opportunity for diagnostic imaging to evaluate the therapeutic feasibility and bene ts of FAPI-based targeted therapy.…”
Section: Discussionsupporting
confidence: 90%
“…25 Many clinical guidelines identify PSMA-PET as an emerging imaging modality that is rapidly becoming part of standard practice. 33,34 Anticipated Future Use of PET-CT…”
Section: Current Standard Of Carementioning
confidence: 99%
“…60 As well, the production yield of cyclotron-produced 18F is higher than that of a 68Ga generator, 6 allowing for around 25 PET-CT exams a day. 34 While centralized production of PSMA radiopharmaceuticals using cyclotrons may provide greater production efficiency and cost-effectiveness when compared to generator-produced radiopharmaceuticals, 61 for provinces with PET-CT that rely on a single cyclotron (which is the case in 6 provinces), unplanned downtime due to technical problems or unanticipated maintenance can create a "single point of failure," which results in the cancellation of patient appointments. 18 Generators allow sites that do not have access to cyclotrons to have a supply of 68Ga PSMA.…”
Section: Cyclotron Production Of Psma-pet Radiopharmaceuticalsmentioning
confidence: 99%
“…The European Association of Nuclear Medicine (EANM) recommendations have only recently been widened to include fluor-18 labeled PSMA tracers [3]. Fluorine-18 as a radionuclide has several advantages compared to gallium-68 [4,5]. Notably, it has a longer half-life, enabling transportation to imaging centers further away from the site of radiolabelling; it is easier to manufacture in large quantities; and the emitted positron has a lower energy which in turn means that the positron range is shorter for fluorine-18 compared to gallium-68.…”
Section: Introductionmentioning
confidence: 99%